Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flavodilol: a new antihypertensive agent.

C R Kinsolving1, B E Watkins, A R Borrelli

  • 1Department of Pharmacology, Pharmaceutical Division of the Pennwalt Corporation, Rochester, New York 14623.

Journal of Cardiovascular Pharmacology
|July 1, 1989
PubMed
Summary

Flavodilol effectively lowers blood pressure in hypertensive rats by reducing norepinephrine release from sympathetic nerves. This novel antihypertensive mechanism targets peripheral noradrenergic function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digestibility of a high-fiber biscuit-based diet by black and white colobus (Colobus guereza).

American journal of primatology·2020
Same author

ES Critical Review: Environmental monitoring by immunoassay.

Environmental science & technology·2012
Same author

Isolation and identification of a direct-acting mutagen in diesel-exhaust particulates.

Environmental science & technology·2012
Same author

Evaluation of simple and looped suture and new material for flexor tendon repair.

The Journal of hand surgery, European volume·2009
Same author

[Expression of platelet-derived growth factor-b and transforming growth factor-beta 1 in the alveolar macrophages of allergic rats].

Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University·2003
Same author

[Effects of retinoic acid on proliferation and differentiation of human lung squamous carcinoma cell line].

Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University·2003

Area of Science:

  • Pharmacology
  • Cardiovascular Research
  • Neuroscience

Background:

  • Hypertension remains a significant global health challenge.
  • Understanding novel antihypertensive drug mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the biological properties and mechanism of action of flavodilol, a new antihypertensive agent.
  • To evaluate flavodilol's efficacy in various rat models of hypertension.

Main Methods:

  • Oral administration of flavodilol to spontaneously hypertensive rats (SHR), normotensive rats, and DOCA/salt hypertensive rats.
  • Assessment of arterial blood pressure (ABP), heart rate (HR), and responses to autonomic stimuli.
  • Investigation of potential interactions with beta-adrenoceptors, dopamine receptors, and prostaglandin synthetase.

Related Experiment Videos

Main Results:

  • Flavodilol dose-dependently lowered ABP in SHR and DOCA/salt hypertensive rats, with effects sustained at higher doses.
  • No significant alteration in ABP was observed in normotensive rats at lower doses.
  • Flavodilol did not affect responses to head-up tilt or influence cardiac output in SHR.
  • The drug did not interact with beta-adrenoceptors, dopamine receptors, or prostaglandin synthetase.
  • Flavodilol treatment attenuated sympathetic nerve-mediated responses and decreased norepinephrine release.

Conclusions:

  • Flavodilol is an effective antihypertensive drug.
  • Its mechanism involves reducing norepinephrine release from postganglionic sympathetic nerves.
  • Flavodilol attenuates peripheral noradrenergic function, offering a new therapeutic approach for hypertension.